Misclassification doesn’t just cause paperwork delays. It can block MHRA registration, trigger enforcement actions, and even lead to product recalls if you place a device on the market under the wrong risk class.
MHRA’s own 2024 registration data shows the trend clearly: around 60% of UK-registered medical devices are Class I, and this group has seen the largest year-on-year rise in compliance audits, a clear sign that low-risk devices are no longer receiving light-touch oversight.
If you’re unsure where your product sits, you’re not alone — borderline classifications and software queries have risen sharply since 2022.
Need help determining your device class? Download Patient Guard’s free UK Classification Checklist.
Understanding Medical Device Classification in the UK
Under the UK MDR 2002, Regulation 7 sets out the four categories of medical devices placed on the Great Britain market:
- Class I
- Class IIa
- Class IIb
- Class III
Risk classification determines:
- Conformity-assessment route
- The depth of clinical evidence required
- Involvement of a UK Approved Body
- UKCA marking requirements
- post-market obligations
The UK MDR 2002 remains broadly aligned with the old EU MDD structure, but the MHRA continues to issue clarifications as part of its transformation programme.
MHRA Medical Device Classification Rules
MHRA applies classification rules based on:
- intended purpose
- duration of contact (transient, short-term, long-term)
- degree of invasiveness
- active functionality
- software algorithms and data interpretation
The UK currently uses 22 classification rules, inherited mainly from EU Annexe VIII before Brexit, covering everything from surgically invasive devices to active therapeutic systems.
These rules help manufacturers navigate borderline situations — for example, when a product lies between a cosmetic tool and a medical device, or when software interprets data in a diagnostic context. Speak to us about our UK MDR Compliance & Registration services.
How to Determine Your Device Class – Step-by-Step Framework
- Define Intended Purpose
The legally binding description of what your device does. - Identify Mode of Action
Pharmacological? Metabolic? Mechanically therapeutic? This determines whether it falls into the medical-device scope. - Review Invasiveness
Duration, anatomical site, and whether surgical access is required. - Software & Digital Functionality
Does the system monitor, diagnose, interpret, or drive therapeutic action? - Apply Classification Rules
Work through all relevant rules, not just one. A device may meet multiple criteria. - Check Borderline Guidance
Essential for cosmetics, wellness devices, software, and AI systems. - Document Your Rationale
MHRA expects a written classification statement with justification.
If you need help classifying your device, refer to the MHRA Borderlines & Classification Guidance information.
UK Medical Device Classes Explained
Class I Medical Device UK
Class I covers low-risk devices. Many can self-declare without an Approved Body unless they are:
- Class Is — sterile
- Class Im — measuring
- Class Ir — reusable surgical instruments
Typical Class I examples:
- non-sterile gloves
- thermometers (non-measuring)
- non-sterile plasters
- simple medical furniture
Accessories also require registration as Class I devices.
Need help with the UK MDR registration of your device? Patient Guard is here to help.
Class IIa Devices
Medium-risk devices that typically contact the body for short durations.
Examples of these include:
- dental fillings
- infusion pumps (low-risk settings)
- diagnostic ultrasound equipment
Class IIa devices require complete technical documentation and involvement of an Approved Body.
Class IIb Devices
Higher-risk devices with longer-term use or deeper interactions. Some examples include:
- long-term surgically invasive devices
- ventilators
- imaging systems used for therapeutic decisions
Approved Body assessment is mandatory for Class IIb devices.
Class III Devices
Highest risk category, often life-supporting or implantable. Examples of these are:
- heart valves
- stents
- neurological implants
- major aesthetic implants (breast implants)
Class III devices require the most comprehensive clinical evidence and scrutiny.
Active, Software, and Borderline Devices
Digital health has dramatically changed MHRA’s case mix. Under the MHRA Software & AI Change Programme (2024), classification is shifting toward more stringent oversight of software that informs diagnosis or treatment.
Statistic:
MHRA 2024 updates report: ~15% year-on-year growth in software and digital health submissions, leading to higher-risk classifications and more borderline queries.
Key software considerations:
- Does the algorithm interpret, diagnose, or recommend treatment?
- Is it purely assistive, or does it change clinical decision-making?
- Does the software drive or control a physical medical device?
SaMD (Software as a Medical Device) often lands in Class IIa or IIb, with some AI-driven diagnostic tools reaching Class III.
Real-World Examples of Device Classification
Here are 10 clear examples illustrating how MHRA applies the rules:
- Surgical gloves (sterile) → Class Is
- Contact lenses → Class IIa
- Spectacle lenses → Class I
- Infusion pump → Class IIb
- Diagnostic ECG monitor → Class IIa
- AI radiology triage tool → Class IIb or III
- Blood glucose meter → Class IIb
- Orthopaedic hip implant → Class III
- Mobile app calculating insulin doses → Class IIb/III
- Wound dressing (non-sterile) → Class I
UK MDR vs EU MDR Classification Rules
The UK’s classification scheme is still similar to the MDD-model Annexe IX, whereas the EU MDR applies the newer, more prescriptive Annexe VIII.
Key differences:
UK (UK MDR 2002) | EU MDR 2017/745 |
Based on MDD Annexe IX | Based on new Annexe VIII |
Approved Bodies | Notified Bodies |
UKCA marking | CE marking |
Transitional measures via 2028–2030 | EU MDR staggered deadlines |
Software classification is still evolving | More prescriptive SaMD rules |
Conformity Assessment and MHRA Registration
Classification dictates the entire compliance path:
Class I
- Self-declaration (except Is, Im, Ir)
- Technical File
- UKCA Declaration of Conformity
Class IIa / IIb / III
- Approved Body assessment
- Clinical evaluation
- PMS plans, PMCF (if required)
- Vigilance system
MHRA Registration (DORS) Requirements
- All devices must be registered before being placed on the market.
- Importers and UK Responsible Persons must complete separate registrations.
Mini Compliance Checklist
- Has the intended purpose been defined precisely?
- Has the classification rationale been documented?
- Is the Technical File aligned with class expectations?
- Has the PMS plan been updated to meet the 2025 requirements?
- Are accessories classified separately?
Common Classification Mistakes (and How to Avoid Them)
- Misinterpreting the intended purpose
Marketing claims creep into clinical claims, altering classification. - Not reassessing classification after software updates
AI and algorithmic changes can trigger higher-risk categorisation. - Incorrect handling of accessories
Accessories are classified independently, not automatically under the primary device. - Using EU MDR classification without checking UK alignment
Post-Brexit divergence is slowly increasing. - Assuming Class I means low scrutiny
MHRA has increased audits and enforcement for Class I devices.
Future of UK Medical Device Classification – 2025 and Beyond
MHRA’s 2025 reform programme is expected to clarify:
- Software classification rules
- Digital-health evidence pathways
- IMDRF alignment for risk classification
- Strengthened post-market requirements
- Future transition deadlines through 2028–2030
Manufacturers should expect greater harmonisation with IMDRF, but also stronger UK-specific expectations in digital health and AI tools. Contact Patient Guard to prepare your classification strategy for the 2025 MHRA reforms.
Conclusion
Accurate medical device classification in the UK is essential for UKCA marking, MHRA registration, and market access. With increasing scrutiny — even for Class I medical devices — manufacturers need reliable classification rationales and updated documentation.
Whether you’re launching a Class I product or preparing a Class III clinical dossier, classification sets the trajectory for compliance success.
Download our UK Device Classification Checklist →
Or speak to Patient Guard for expert classification support →
Frequently Asked Questions
Use intended purpose, invasiveness, duration, software use, and MHRA’s 22 classification rules to justify the class.
Low-risk devices such as non-sterile gloves, simple dressings, or basic monitoring tools — unless sterile, measuring, or reusable surgical.
The UK uses 22 rules determining classification based on invasiveness, duration, software functions, and active characteristics.
The UK follows the older MDD-style framework, while the EU MDR uses Annexe VIII with more stringent software rules.
Possible MHRA enforcement, rejected registrations, conformity-assessment failure, and product recall.
Absolutely. Patient Guard supports manufacturers from initial classification through Technical File development and MHRA DORS registration.
Patient Guards Recent Posts
CE Marking vs UKCA: 2026 Guide for Manufacturers
Post-Brexit, many medical device manufacturers are still navigating the split between CE marking and the UKCA mark — and the rules keep evolving. As the MHRA advances its “future regime” for medical devices, regulatory teams face the ongoing challenge of complying with both EU MDR obligations and the UK’s own UK MDR 2002 (as amended) framework.
ISO 10993-1:2025 – What’s New in Biological Evaluation
The newly revised ISO 10993-1:2025 has quietly done something big: it’s turned biological evaluation from a “tick-the-box biocompatibility test list” into a fully integrated risk narrative that regulators now expect to hold together scientifically, from chemistry through to clinical data.
EUDAMED Mandatory from May 2026: What You Need to Know
After years of “coming soon”, the EU has finally put a fixed date on reality: the first EUDAMED mandatory modules must be used from 28 May 2026.
